Day: March 10, 2022

Ms. Opal Lee, The Nobel Peace Prize Nominee, and Grandmother of Juneteenth, Signed with Creative Artists Agency

Fort Worth, TX, March 10, 2022 (GLOBE NEWSWIRE) — Unity Unlimited, Inc.’s very own ‘Grandmother of Juneteenth’  Ms. Opal Lee, has signed with Creative Artists Agency (CAA), the world’s leading entertainment and sports agency, to obtain talent representation as she campaigns for unity and freedom around the globe. Ms. Opal began her mission in 2016 with a […]

EMGA advises on US$200M debt raise for BTG Pactual with JICA

LONDON, March 10, 2022 (GLOBE NEWSWIRE) — Emerging Markets Global Advisory Limited (EMGA), the niche investment bank focused on emerging markets, announces today another landmark Senior Debt capital raise transaction that will allow BTG Pactual to continue the expansion of its small and medium-sized enterprise (SME) lending activities in Brazil. The US$200 million debt facility […]

ResMed Announces Participation in the Oppenheimer 32nd Annual Healthcare Conference

SAN DIEGO, March 10, 2022 (GLOBE NEWSWIRE) — ResMed (NYSE: RMD, ASX: RMD) today announced Rob Douglas, president and chief operating officer, will present at the Oppenheimer 32nd Annual Healthcare Conference on Tuesday, March 15, 2022, beginning at approximately 1:20 p.m. (Eastern Daylight Time) via webcast. More information about this event, including access to the […]

Eagle Eye Networks Introduces Eagle Eye LPR, Making Highly Accurate License Plate Recognition Possible with any Security Camera

Eagle Eye LPR Makes License Plate Recognition Practical and Affordable The newest enhancement to the Eagle Eye Cloud VMS (video management system), Eagle Eye LPR/ANPR is AI-powered, cloud-managed, and does not require the purchase of special cameras AUSTIN, Texas, March 10, 2022 (GLOBE NEWSWIRE) — Eagle Eye Networks, the global leader in cloud video surveillance, today launched Eagle Eye LPR […]

Health Canada Approves Samsung Bioepis and Biogen’s BYOOVIZ™ (SB11), LUCENTIS® Biosimilar (ranibizumab)

BYOOVIZ™ becomes the first Lucentis® biosimilar to be approved in Canada following its approval in Europe and the United States in 2021 INCHEON, Korea and TORONTO, March 10, 2022 (GLOBE NEWSWIRE) — Samsung Bioepis Co., Ltd. and Biogen Canada Inc. today announced that Health Canada has approved BYOOVIZ™ – a biosimilar referencing LUCENTIS®i (ranibizumab) – for the treatment […]

Back To Top